Abstract: A series of novel derivatives of phenyl-substituted berberine triazolyls has been designed and synthesized via copper-catalyzed azide-alkyne cycloaddition click chemistry in an attempt to develop antitumor agents. All of the compounds were evaluated for anticancer activity against a panel of three human cancer cell lines, including MCF-7 (breast), SW-1990 (pancreatic), and SMMC-7721 (liver) and the noncancerous human umbilical vein endothelial cell (HUVEC) cell lines. The results indicated that most of the compounds displayed notable anticancer activities against the MCF-7 cells compared with berberine. Among these derivatives, compound 16 showed the most potent inhibitory activity against the SW-1990 and SMMC-7721 cell lines, with half-maximal inhibitory concentration (IC 50 Furthermore, compounds 14, 15, 16, 17, 18, 32 , and 36 exhibited much better selectivity than berberine toward the normal cell line HUVEC.
Introduction
In the past several decades, researchers have struggled to find effective clinical approaches for the treatment of cancer and have searched for novel anticancer agents. [1] [2] [3] Berberine, an isoquinoline alkaloid isolated from the roots and stem bark of the Berberis species, is widely used as a traditional medicine for treating diarrhea and gastrointestinal disorders. 4 In the past several years, berberine has shown a wide range of biochemical and pharmacological activities. [5] [6] [7] [8] [9] [10] [11] Research on the anticancer activity of berberine in particular has received widespread attention and has achieved fairly good results. [12] [13] [14] [15] [16] [17] [18] [19] However, berberine was poorly absorbed in the intestines and thus showed a low inhibitory effect on cancer cell growth, which seriously affected the application prospects of berberine as an anticancer drug. [20] [21] The concept of "click" chemistry was introduced in 2001. The catchy term "click" refers to the facile, efficient, selective, and versatile chemical transformations that lead to a single reaction product. 22, 23 Although different chemical reactions (eg, cycloadditions, nucleophilic substitutions, additions to carbon-carbon double bonds) can be considered to be of the "click" type, copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) is regarded as a prime example of "click" chemistry. 24, 25 This reaction is regioselective, chemoselective, and moreover can be performed in aqueous medium at room or physiological temperature. Several recent reports have confirmed that CuAAC is a very useful method in bioapplications as diverse as drug discovery, drug delivery, and gene therapy. [26] [27] [28] [29] [30] [31] [32] Thus, CuAAC has become a very popular tool in drug research.
To enhance the inhibitory function of berberine, the functionalized benzyl-modif ied berberine derivative compounds 4-36 were synthesized via CuAAC "click" chemistry from berberrubine and relevant azides and screened for cytotoxicity in vitro in human MCF-7 breast adenocarcinoma cells, human SW-1990 pancreatic carcinoma cells, and human SMMC-7721 liver carcinoma cells. This study is presented in two parts for clarity, the synthesis of new triazolyl berberine derivatives and the results of testing their anticancer properties. Several types of functional groups, specifically triazolyl berberine derivatives, were investigated to determine the structure-activity relationship.
Materials and methods

Synthesis and purification of triazolyl berberine derivatives
In this study, 33 triazolyl berberine derivatives were synthesized. This is the first report of any of them. The initial synthesis of the triazolyl berberine derivatives is illustrated in Figure 1 . First, structural modifications at berberine C-9 (compound 1) can be envisaged after converting the methoxy group to a hydroxyl to obtain berberrubine (compound 2). Stirring compound 1 with dimethylformamide (DMF) at 190°C yielded berberrubine. 33 Second, compound 3 was synthesized with an overall yield of 60% from berberrubine and propargyl bromide by a nucleophilic substitution reaction. Azides were prepared from their corresponding benzyl halides by diazotization in acidic conditions followed by displacement with sodium azide, with good to excellent yield (approximately 85% yield). Reaction of compound 3 with aromatic azides in the presence of CuSO 4 ⋅ 5H 2 O and sodium ascorbate in DMF resulted in the derivatives 4-36 in excellent yields. The structures of the synthesized target compounds were elucidated by 1 H nuclear magnetic resonance (NMR), 13 C NMR, and mass spectrometry (MS). By employing the above reaction conditions, a series of triazolyl berberine derivatives that have varied substitutions on the aromatic ring were synthesized from a range of aromatic azides. All spectral data were in accordance with the assumed structures.
Chemistry
1 H NMR and 13 C NMR spectra were recorded using tetramethylsilane (TMS) as the internal standard in di methyl sulfoxide (DMSO)-d 6 with a Bruker BioSpin GmbH (Billerica, MA, USA) spectrometer at 300 MHz and 75 MHz, respectively. The chemical shifts are reported in ppm relative to TMS as the internal standard, and coupling constants were measured in Hz. Electrospray ionization (ESI)-MS was recorded on an Agilent 1100 LC/MSD (70 eV) spectrometer (Agilent Technologies, Santa Clara, CA, USA). High-resoution mass spectrometry was recorded on a Waters Micromass ® Q-Tof micro™ mass spectrometer (Milford, MA, USA). All other reagents and starting materials were purchased and used as received (Sigma-Aldrich Co, St Louis, MO, USA; Tokyo Chemical Industry Co, Ltd, Tokyo, Japan; Adamas Reagent, Ltd, Shanghai, China). Reactions were monitored by analytical thin-layer chromatography (TLC) using silica gel 60 F254 plates, and spots were visualized by ultraviolet light irradiation (254 nm). Flash column chromatography was performed with silica gel (200-300 mesh). All reagents were purchased from Sigma-Aldrich Co, (St Louis, MO, USA). All solvents and reagents were analytical pure, and no further purification was needed. All starting materials were commercially available.
To a solution of NaN 3 (50 mg, 0.77 mmol) in DMF (10 mL), a benzyl compound (0.6 mmol) was added, and the reaction mixture was sonicated at 35°C until completion, monitored by TLC. Compound 3 (160 mg, 0.4 mmol), CuSO 4 ⋅5H 2 O (30 mg, 0.12 mmol) and sodium ascorbate (50 mg, 0.25 mmol) were added to this mixture. The mixture was stirred at room temperature for 3 hours, filtered and then evaporated under vacuum, while being monitored by TLC. The crude mixture was extracted with 
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Preparation of novel berberine derivatives as potential anticancer agents dichloromethane (3×40 mL), and the combined organic layer was dried over sodium sulfate and purified through column chromatography to give pure compounds 4-36 at 50%-90% yields.
Synthesis of berberrubine (compound 2)
Commercially available berberine (compound 1, 1.1 g) chloride was heated at 190°C in a vacuum oven under reduced pressure (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) 
Synthesis of 9-O-(propyne) berberine chloride (compound 3)
To a solution of compound 2 (540 mg, 1 mmol) in acetonitrile, propargyl bromide (240 mg, 1.2 mmol) was added and the reaction mixture was stirred at 75°C for 4 hours. Reaction was monitored by TLC and the crude product was subjected to column chromatography to give pure compound 3 (350 mg, 65% yield). general procedure for the synthesis of compounds To a solution of NaN 3 (50 mg, 0.77 mmol) in DMF (10 mL), compound of benzyl (0.6 mmol) was added and the reaction mixture was sonicated at 35°C until completion, monitored by TLC. To this mixture, compound 3 (160 mg, 0.4 mmol), CuSO 4 ⋅ 5H 2 O (30 mg, 0.12 mmol) and sodium ascorbate (50 mg, 0.25 mmol) were added. The mixture was stirred at room temperature for 3 hours, filtered, and then evaporated under vacuum, monitored by TLC. The crude mixture was extracted with dichloromethane (3×40 mL) and the combined organic layer was dried over sodium sulfate and purified through column chromatography to give pure compounds 4-36 in 50%-90% yield. 
9-O-[1-(4-methyl formate benzyl)-4-ethyl-1H-1, 2, 3-triazole] berberine chloride (compound 25)
9-O-[1-(4-(methylsulfonyl)benzyl-4-ethyl-1H-1, 2, 3-triazole) berberine chloride (compound 26)
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Cytotoxic activity
The in vitro cytotoxicity of the newly synthesized target compounds 4-36 against MCF-7, SW-1990, SMMC-7721, and HUVEC cell lines was measured by an assay was based on the cleavage of the yellow tetrazolium salt MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (Sigma-Aldrich) to form purple formazan crystals in viable cells. The cells were plated in 96-well culture plates at a density of 10,000 (MCF-7), 5,000 (SW-1990), 6,000 (SMMC-7721), and 5,000 (HUVEC) cells per well and incubated for 24 hours at 37°C in a 5% CO 2 incubator. The compounds were dissolved in DMSO and diluted with culture medium. The compounds were added to the wells at final concentrations of 1.95, 3.9, 7.8, 15.625, 31.25, 62.5, 125, and 250 µM before incubation at 37°C in a 5% CO 2 incubator for 48 hours. After that, the cells were treated with 10% volume ratio (v/v) MTT dye solution (5 mg/mL) for 4 hours. The media with MTT solution was replaced with DMSO (150 µL). The 96-well culture plates were then gently shaken in the dark for 30 minutes, and absorbance at 570 nm and 630 nm (background) was measured with a microtiter plate reader. The half-maximal inhibitory concentration (IC 50 ) value was determined from the chart of cell viability (%) against compound dose (µM). 34 In vitro cytotoxic activities were evaluated for all synthesized compounds against the MCF-7, SW-1990, SMMC-7721, and HUVEC cell lines. Berberine was taken Drug Design, Development and Therapy 2014:8 submit your manuscript | www.dovepress.com
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Preparation of novel berberine derivatives as potential anticancer agents as the reference standard in this study. Berberine and compounds 4-36 were dissolved in DMSO and diluted with culture medium containing 0.1% DMSO. Cells were treated with culture medium containing 0.1% DMSO. The percent inhibition of viability at each concentration of the compounds was calculated with respect to the control, and IC 50 values were estimated with the software SPSS version 16.0 for Windows (SPSS Inc., Chicago, IL, USA). Each experiment was repeated three times, and the results are summarized in Table 1 . The response parameter calculated was IC 50 values (Table 1) , which corresponded to the compound concentration causing 50% mortality in net cells.
Statistical analysis
Each experiment was performed at least in triplicate. The data are presented as mean ± standard deviation. Using analysis of variance, statistical significance was determined. Mean values with probability values of P,0.05 were taken as statistically significant. (Figure 2) , which is much better than the reference drug berberine and other target compounds. From the data, we can indicate that adding disubstituted groups on the phenyl ring of compounds 27-35 showed moderate effect against three human cancer cell lines. However, compounds 32-35 had a dichlorine group at the R position and had enhanced activity compared to that of other electron-withdrawing group derivatives (compounds [27] [28] [29] [30] [31] BBR  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34 
1058
Jin et al
Compared to compound 32 (R=−2, 4-2Cl) the activity of compound 30 (R=−2-F, 4-Cl) was weaker. Similarly, compound 27 had 2-4-difluorine substituents on the phenyl group, but the cytotoxicity of compound 27 against the three cancer cell lines was lower than that of compound 31 (R=−2-Br, 4-F).
Conclusions
This study described the construction of a new series of triazole-containing berberine derivatives using CuAAC "click" chemistry. All of the compounds synthesized were screened for anticancer activity against a panel of three human cancer cell lines, MCF-7 (breast), SW-1990 (pancreatic), and SMMC-7721 (liver), and the noncancer HUVEC (human umbilical vein endothelial cell) cell line. From the data, it was evident that most of the target compounds exhibited better anticancer activity against all the tested cancer cell lines than the reference drug berberine used in this study. Compounds 16 and 36, which had tert-butyl and 1,3,5-trichlorosubstituents on the phenyl group, were the most promising target compounds. It was noted that highly active anticancer compounds showed lower cytotoxicity to the noncancerous HUVEC cells compared with berberine. Detailed mechanistic studies are currently underway in our laboratory.
